Stocks in Play: Bausch Health Companies Inc.

Thursday, April 8, 2021

9:57 AM EST – Bausch Health Companies Inc. : Announced the U.S. launch of its novel daily over-the-counter probiotic supplement, ENVIVE™. ENVIVE™ is shown to help reduce the severity and frequency of five occasional gastrointestinal (GI) symptoms – diarrhea, constipation, gas, bloating and discomfort – and help strengthen and protect the digestive system by strengthening the gut barrier. ENVIVE™ is proven to help relieve these occasional GI symptoms in as little as two weeks.* Bausch Health Companies Inc. (T.BHC) shares were down $0.08 at 39.73.

Stocks in Play: Bausch Health Companies Inc., Thu, 08 Apr 2021 10:00:02 EST

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire